UB Paderborn / Katalog / Suche / in CDI

Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival

Journal of clinical oncology, 2011-06, Vol.29 (18), p.2493-2498

2011

Volltextzugriff (PDF)

Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial

Journal of clinical oncology, 2012-03, Vol.30 (9), p.907-913

2012

Volltextzugriff (PDF)

Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell–engaging CD19/CD3-bispecific BiTE antibody blinatumomab

Blood, 2012-06, Vol.119 (26), p.6226-6233

2012

Volltextzugriff (PDF)

CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells

Cancer research (Chicago, Ill.), 2006-11, Vol.66 (22), p.10995-11004

2006

Volltextzugriff (PDF)

Genetically engineered attenuated measles virus specifically infects and kills primary multiple myeloma cells

Journal of general virology, 2009-03, Vol.90 (3), p.693-701

2009

Volltextzugriff (PDF)

Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom)

Blood, 2009-04, Vol.113 (18), p.4137-4143

2009

Volltextzugriff (PDF)

Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans

Blood, 2011-06, Vol.117 (22), p.5881-5891

2011

Volltextzugriff (PDF)

Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma

British journal of haematology, 2010-02, Vol.148 (3), p.480-482

2010

Volltextzugriff (PDF)

Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus

Blood, 2006-03, Vol.107 (6), p.2562-2569

2006

Volltextzugriff (PDF)

Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants

Blood, 2004-05, Vol.103 (9), p.3565-3572

2004

Volltextzugriff (PDF)

T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B–lineage leukemia effect

Blood, 2003-02, Vol.101 (4), p.1637-1644

2003

Volltextzugriff (PDF)

Selective depletion of alloreactive T cells by targeted therapy of heat shock protein 90: a novel strategy for control of graft-versus-host disease

Blood, 2009-09, Vol.114 (13), p.2829-2836

2009

Volltextzugriff (PDF)

Highly efficient gene transfer into baboon marrow repopulating cells using GALV-pseudotype oncoretroviral vectors produced by human packaging cells

Blood, 2002-12, Vol.100 (12), p.3960-3967

2002

Volltextzugriff (PDF)

Effect of serum and CTL on focal growth of human cytomegalovirus

Journal of clinical virology, 2007-02, Vol.38 (2), p.112-119

2007

Volltextzugriff (PDF)

Enhanced transgene expression in quiescent and activated human CD8+ T cells

Human gene therapy, 2004-07, Vol.15 (7), p.648-658

2004

Volltextzugriff (PDF)

Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies

Cancer research (Chicago, Ill.), 1995-05, Vol.55 (10), p.2173-2176

1995

Volltextzugriff (PDF)

Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD 154

Blood, 2011, Vol.118 (4), p.1121-1131

2011

Volltextzugriff (PDF)

Epoetin Alfa in Patients With Advanced-Stage Hodgkin's Lymphoma: Results of the Randomized Placebo-Controlled GHSG HD 15EPO Trial

Journal of clinical oncology, 2010, Vol.28 (13), p.2239-2245

2010

Volltextzugriff (PDF)

An antiproliferative bioassay for interleukin-4

Journal of immunological methods, 1996-01, Vol.189 (1), p.129-135

1996

Volltextzugriff (PDF)

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

The Lancet (British edition), 2012-05, Vol.379 (9828), p.1791-1799

2012

Volltextzugriff (PDF)

STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90α and β in multiple myeloma cells, which critically contribute to tumor-cell survival

Blood, 2007-01, Vol.109 (2), p.720-728

2007

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival

Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial

Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell–engaging CD19/CD3-bispecific BiTE antibody blinatumomab

Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL

CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells

Genetically engineered attenuated measles virus specifically infects and kills primary multiple myeloma cells

Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom)

Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans

Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma

Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus

Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants

T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B–lineage leukemia effect

Selective depletion of alloreactive T cells by targeted therapy of heat shock protein 90: a novel strategy for control of graft-versus-host disease

Highly efficient gene transfer into baboon marrow repopulating cells using GALV-pseudotype oncoretroviral vectors produced by human packaging cells

Effect of serum and CTL on focal growth of human cytomegalovirus

Enhanced transgene expression in quiescent and activated human CD8+ T cells

Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies

Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD 154

Epoetin Alfa in Patients With Advanced-Stage Hodgkin's Lymphoma: Results of the Randomized Placebo-Controlled GHSG HD 15EPO Trial

An antiproliferative bioassay for interleukin-4

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90α and β in multiple myeloma cells, which critically contribute to tumor-cell survival

Aktive Filter

Suchergebnisse filtern